Litfulo 50 mg
Litfulo 50 mg is a medicine authorised by Swissmedic under authorisation number 69695. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 February 2025 and the authorisation is limited until 02 February 2030. ATC code L04AF08 places the medicine in the group Immunosuppressants.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Litfulo 50 mg, Hartkapseln | B | 03 February 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | L04AF08 | 07.15.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Litfulo 50 mg authorised in Switzerland?
Yes. Litfulo 50 mg is authorised by Swissmedic under authorisation number 69695, data as of 01 September 2026. The authorisation is limited until 02 February 2030.
Which dispensing category does Litfulo 50 mg have?
Litfulo 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Litfulo 50 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.